The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Cmbio: Advancing Microbiome Innovation Through Digital Biology
Pharma & Human Health

Cmbio: Advancing Microbiome Innovation Through Digital Biology

MAR 5, 2026
Missing microbes in UK infant gut and probiotics highlighted by global microbiome atlas
Biotics and Supplements

Missing microbes in UK infant gut and probiotics highlighted by global microbiome atlas

MAR 5, 2026
How Oral Drugs and Nutrition impacts Microbiome: Realistic Dynamic In Vitro Microbiome Modeling
Gastrointestinal

How Oral Drugs and Nutrition impacts Microbiome: Realistic Dynamic In Vitro Microbiome Modeling

FEB 26, 2026
Global scientific paper establishes first consensus definition of gut health
Gastrointestinal

Global scientific paper establishes first consensus definition of gut health

FEB 20, 2026
Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
Editor's Choice

Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis

FEB 11, 2026
Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way
Pharma & Human Health

Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way

FEB 5, 2026
Immunity as a Lifestyle Priority
Editor's Choice

Immunity as a Lifestyle Priority

JAN 30, 2026
‘GABA Factory’ Probiotic LP815® Improves Sleep and Reduces Stress
Biotics and Supplements

‘GABA Factory’ Probiotic LP815® Improves Sleep and Reduces Stress

JAN 22, 2026
EnteroBiotix announces positive Phase 2 results for potential first-in-class, oral, full-spectrum microbiome therapy for IBS
Clinical & Manufacturing

EnteroBiotix announces positive Phase 2 results for potential first-in-class, oral, full-spectrum microbiome therapy for IBS

JAN 8, 2026
AOB Pharma receives EMA positive decision on the Pediatric Investigation Plan for development of B244
Pharma & Human Health

AOB Pharma receives EMA positive decision on the Pediatric Investigation Plan for development of B244

DEC 9, 2025
UC San Diego researchers develop new tool to predict how bacteria influence health
Pharma & Human Health

UC San Diego researchers develop new tool to predict how bacteria influence health

NOV 28, 2025